Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2022-03-10 Director's Dealing
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
111年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by insiders and directors of the company 生達化學製藥股份有限公司. It lists share counts, pledged shares, and relationships of insiders, including directors and executives. There is no indication of financial results, earnings, management discussion, or report publication. The content focuses on insider shareholdings and pledges, which corresponds to disclosures about directors' dealings or insider share transactions. However, it does not report specific transactions but rather current holdings and pledges. Given the nature of the data, it best fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is short and focused on insider holdings, not a full report or announcement of voting results or capital changes. Therefore, the classification is DIRS with high confidence.
2022-03-10 Chinese
111年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document contains financial data related to loan balances and guarantee information for the company and its subsidiaries, presented in a tabular format with monetary amounts. It is a short document (611 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial status rather than a full financial report or announcement. There is no indication of it being an annual or interim report, audit report, or any other specific filing type. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2022-03-09 Chinese
111年2月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary revenue report from a listed company, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards and reporting practices but does not contain comprehensive financial statements or detailed analysis. The document length is short (766 characters) and it appears to be a brief financial data summary rather than a full report. It is not an announcement of a report publication but a direct data disclosure. Given the nature of the content as a brief summary of key financial facts, it fits best into the Fund Information / Factsheet (FS) category.
2022-03-09 Chinese
111年1月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (768 characters), and it appears to be a brief financial data summary rather than a full report or announcement. It does not announce a report publication or voting results, nor is it a regulatory filing or certification. Given the concise financial data summary nature, it best fits the category of Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2022-02-14 Chinese
111年1月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document is a financial disclosure from a listed company providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. It is a short document (611 characters) and contains specific financial data related to fund lending and guarantees, but it does not present a full financial report or comprehensive analysis. It appears to be a regulatory disclosure or compliance update rather than a full report like an Annual Report or Interim Report. Given the nature and length, and that it does not fit other specific categories, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures.
2022-02-14 Chinese
111年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of insiders, including directors, executives, and their related parties, with specific numbers of shares held, changes in holdings, and classifications of shares. The content focuses on personal share transactions and holdings by company insiders. There is no indication of financial results, management discussion, or report publication. The document is not a general regulatory filing or announcement but a detailed insider shareholding report. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures rather than other categories.
2022-02-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.